• Home
  • About
    • Our Approach
    • Guiding Principles
    • Leadership
    • Leadership in the News
    • Board of Directors
    • Scientific Advisory Board
    • Ophthalmology Advisory Board
  • Technology
    • Platform
    • Product Engine
  • Pipeline
    • Pipeline
    • Clinical Candidates
  • Scientific Presentations
  • Our Purpose
    • Ophthalmic Diseases
    • Pulmonary Diseases
    • Cardiology Diseases
  • Investors
  • Careers
    • Join our Team
    • Living our Guiding Principles
    • 4Diversity
    • What We Offer
    • Open Positions
  • Contact
  • Search
  • Menu Menu

David Kirn, MD

John F. Milligan, PhD

Jacob Chacko, MD, MBA

Susannah Gray, MBA

Nancy Miller-Rich

Charles Theuer, MD, PhD

Shawn Tomasello, MBA

About 4DMT

Our 4DMT genetic medicine engine holds the potential to generate transformative therapies that have the power to improve patient lives, or even cure disease.

Navigation

  • Home
  • About
    • Our Approach
    • Guiding Principles
    • Leadership
    • Leadership in the News
    • Board of Directors
    • Scientific Advisory Board
    • Ophthalmology Advisory Board
  • Technology
    • Platform
    • Product Engine
  • Pipeline
    • Pipeline
    • Clinical Candidates
  • Scientific Presentations
  • Our Purpose
    • Ophthalmic Diseases
    • Pulmonary Diseases
    • Cardiology Diseases
  • Investors
  • Careers
    • Join our Team
    • Living our Guiding Principles
    • 4Diversity
    • What We Offer
    • Open Positions
  • Contact

Location

5858 Horton St. Suite 455
Emeryville, CA 94608

(510) 505-2680
info@4dmt.com

© 2025 4D Molecular Therapeutics. All rights reserved.

  • Contact
  • Privacy Notice
  • Site Terms
Scroll to top